Key Events This Week
2 Mar: Significant gap down opening and intraday volatility
5 Mar: Valuation shifts to fair from expensive amid mixed market sentiment
6 Mar: Week closes at ₹646.75, down 8.84% for the week
Mar 25
BSE+NSE Vol: 4.42 lacs

Yatharth Hospital & Trauma Care Services Ltd is rated Sell by MarketsMOJO. This rating was last updated on 06 Feb 2026. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 25 March 2026, providing investors with an up-to-date analysis of the company’s standing.
Read full news article
Yatharth Hospital & Trauma Care Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Yatharth Hospital & Trauma Care Services Ltd has experienced a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, signals a diminished price attractiveness relative to its historical averages and peer group. Investors should carefully analyse these valuation dynamics amid the company’s recent market performance and sector context.
Read full news article
2 Mar: Significant gap down opening and intraday volatility
5 Mar: Valuation shifts to fair from expensive amid mixed market sentiment
6 Mar: Week closes at ₹646.75, down 8.84% for the week

Yatharth Hospital & Trauma Care Services Ltd has recently undergone a notable change in its valuation parameters, shifting from an expensive to a fair valuation grade. This adjustment, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the hospital sector’s evolving landscape. Despite a recent downgrade in its overall Mojo Grade to Sell, the stock’s valuation now appears more attractive relative to its historical averages and peer group, warranting a closer examination of its price dynamics and market positioning.
Read full news article
Yatharth Hospital & Trauma Care Services Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 03 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Yatharth Hospital & Trauma Care Services Ltd witnessed a sharp decline at market open on 2 Mar 2026, opening with a gap down of 8.1% amid broader sector underperformance and a downgrade in its Mojo Grade. The stock’s weak start reflects heightened market concerns despite a positive one-month performance relative to the Sensex.
Read full news article
Yatharth Hospital & Trauma Care Services Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 06 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 20 February 2026, providing investors with the latest perspective on the company’s position.
Read full news articleWe hereby submit intimation regarding Schedule of Investors Meet.
We hereby submit intimation regarding Schedule of Investors Visit.
We hereby submit the intimation related to Personnels authorized for determining Materiality of events/information.
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available